Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: Evidence for the legacy effect of surgery

Diabetes Care

Volumn 39, Issue 8, 2016, Pages 1400-1407

  Coleman, Karen J ^a   Haneuse, Sebastien ^b   Johnson, Eric ^c   Bogart, Andy ^d   Fisher, David ^a   O'Connor, Patrick J ^e   Sherwood, Nancy E ^e   Sidney, Steve ^a   Theis, Mary Kay ^c   Anau, Jane ^c   Schroeder, Emily B ^a   O'Brien, Rebecca ^a   Arterburn, David ^c  

^a KAISER PERMANENTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d RAND CORPORATION   (United States)

^e Health Partners   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; REMISSION; RETINOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BARIATRIC SURGERY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84980349686     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0194     Document Type: Article

References (26)

1. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248-256.e5
2. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585
3. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316-323
4. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370:2002-2013
5. Ikramuddin S, Korner J, Lee WJ, et al. Rouxen-γ gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013; 309:2240-2249
6. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013; 23:93-102
7. Arterburn D, Bogart A, Coleman KJ, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract 2013; 7:e258-e268
8. Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 6:254-259
9. DiGiorgi M, Rosen DJ, Choi JJ, et al. Reemergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Relat Dis 2010; 6:249-253
10. Cohen R, Pechy F, Petry T, Correa JL, Caravatto PP, Tzanno-Martins C. Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus. J Bras Nefrol 2015; 37:399-409
11. Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 2013; 216:545-556; discussion 556-558
12. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589
13. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular diseasein patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653
14. Healthcare Systems Research Network. Available from http://www.hcsrn.org/en/. Accessed 21 January 2016
15. Ross TR, Ng D, Brown JS, et al. The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration. EGEMS (Wash DC) 2014; 2:1049
16. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32:2133-2135
17. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparisonofrisk prediction using the CKDEPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307:1941-1951
18. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377-399
19. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311:2297-2304
20. Coleman KJ, Huang YC, Koebnick C, et al. Metabolic syndrome is less likely to resolve in Hispanics and non-Hispanic blacks after bariatric surgery. Ann Surg 2014; 259:279-285
21. Banks J, Adams ST, Laughlan K, et al. Roux-en-Y gastric bypass could slow progression of retinopathy in type 2 diabetes: a pilot study. Obes Surg 2015; 25:777-781
22. Brynskov T, Laugesen CS, Svenningsen AL, Floyd AK, Sorensen TL. Monitoring of diabetic retinopathy in relation to bariatric surgery: a prospective observational study. Obes Surg 2016; 26:1279-1286
23. Miras AD, Chuah LL, Lascaratos G, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care 2012; 35:e81
24. Murphy R, Jiang Y, Booth M, et al. Progression of diabetic retinopathy after bariatric surgery. Diabet Med 2015; 32:1212-1220
25. Amin AM, Wharton H, Clarke M, Syed A, Dodson P, Tahrani A. The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: A retrospective cohort study. Surg Obes Relat Dis 2016; 12:606-612
26. Singh RP, Gans R, Kashyap SR, et al. Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Diabetes Care 2015; 38:e32-e33